Suebpong Tanasanvimon

机构：Chulalongkorn University, King Chulalongkorn Memorial Hospital · ORCID：0000-0002-3904-4719

发表论文 120 篇 · 总被引 4041 次 · h-index 17

代表论文

• Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study (2025 · Journal of Hepatology · 被引 87)
• Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer (2025 · ESMO Open · 被引 12)
• One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequency ablation (2025 · Gastrointestinal Endoscopy · 被引 9)
• Corrigendum to “Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer” (2024 · ESMO Open · 被引 2)
• The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma (2026 · Clinical Cancer Research · 被引 1)
• Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial (2026 · JMIR Formative Research · 被引 1)